Condition
Double Expressor DLBCL clinical trials and research
Research outlook What's coming for Diffuse large B-cell lymphoma: the next 6 months to 5 yearsAs of November 12, 2026, Find a Trial lists 2 Double Expressor DLBCL clinical trials that are recruiting, at sites in 2 countries (most in China (1), United States (1)). 1 was first registered in the last 30 days. By phase: Phase 2 (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 1New in 30 days
- 2Countries
All recruiting trials (2)
-
Chidamide, Lenalidomide, and Rituximab as induction therapy for newly diagnosed elderly or unfit double-expressor DLBCL
This trial tests whether the combo of chidamide, lenalidomide, and rituximab can help treat newly diagnosed double-expressor DLBCL in people who are elderly or not fit for standard chemotherapy.
-
Testing blood for cancer DNA in patients with B-cell lymphoma
This study is testing if a blood test for cancer DNA can help identify patients with B-cell lymphoma who are at risk of having their cancer come back in the brain or spinal cord, even when other tests show no signs of it.
Related topics
Quick answers
How many Double Expressor DLBCL clinical trials are recruiting right now?
2, as of November 12, 2026. 1 of them was first registered in the last 30 days. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in China (1 trial), United States (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 2. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.